U.S. patent number D812,232 [Application Number D/561,051] was granted by the patent office on 2018-03-06 for glucose monitoring system.
This patent grant is currently assigned to Medika Therapeutics, Inc.. The grantee listed for this patent is Medika Therapeutics, Inc.. Invention is credited to SingFatt Chin.
United States Patent |
D812,232 |
Chin |
March 6, 2018 |
Glucose monitoring system
Claims
CLAIM I claim the ornamental design for a glucose monitoring
system, as shown and described.
Inventors: |
Chin; SingFatt (Pleasanton,
CA) |
Applicant: |
Name |
City |
State |
Country |
Type |
Medika Therapeutics, Inc. |
Fremont |
CA |
US |
|
|
Assignee: |
Medika Therapeutics, Inc.
(Fremont, CA)
|
Appl.
No.: |
D/561,051 |
Filed: |
April 12, 2016 |
Current U.S.
Class: |
D24/186 |
Current International
Class: |
2401 |
Field of
Search: |
;D24/186,107,111,160,164-165,167-169,183-184,187,216-234
;D10/46,81,104.1 ;D14/126,371,381 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Laymon; Wan
Assistant Examiner: Booker; Mark
Description
FIG. 1 is a three-dimensional view of a glucose monitoring system
showing my new design;
FIG. 2 is another three-dimensional view of the glucose monitoring
system shown in FIG. 1;
FIG. 3 is a side view of the glucose monitoring system shown in
FIG. 1;
FIG. 4 is a top view of the glucose monitoring system shown in FIG.
1;
FIG. 5 is a bottom view of the glucose monitoring system shown in
FIG. 1;
FIG. 6 is a front view of the glucose monitoring system shown in
FIG. 1; and,
FIG. 7 is a rear view of the glucose monitoring system shown in
FIG. 1.
The portions of the articles shown in broken lines form no part of
the claimed design.
* * * * *